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of tumors in different tissues including the pancreas [10] [11] [12] . The proposed mechanism for the regulation of carcinogenesis is the transcriptional modulation of specific target genes that contribute to the transformed phenotype. For instance, GLI1, a candidate oncogene for a number of neoplasms, increases the expression of antiapoptotic molecules (BCL-2, BFL-1/A1 and 4-1BB) [13] [14] [15] , thus increasing the survival of cancer cells. Further characterization of GLI target genes will be key to better define the role of these molecules in carcinogenesis.
GLI activity is regulated by the Hedgehog ligand via 2, multitransmembrane proteins, named PATCHED (PTC) and SMOOTHENED (SMO). In this receptor complex, PTC is the ligand-binding subunit, while SMO is the sig- naling component. Upon binding of Hedgehog to its receptor PTC, an inhibitory effect of PTC on SMO is released, allowing SMO to trigger a signaling cascade that activates the GLI transcription factors [2, 4] . Figure 1 b demonstrates the inactive and active states of this pathway that was largely assembled from genetic studies in Drosophila melanogaster . In the absence of ligand ( fig. 1 b,  left) , the Hedgehog signaling pathway is inactive. In this case, the transcription factor GLI is sequestered by the cytoplasmic complex including COSTAL, FUSED and Suppressor of FUSED (SUFU) [2, 4] . Phosphorylation of GLI by PKA, GSK3 and CK1 targets GLI proteins to proteasome-dependent processing to generate the repressor form of these transcription factors. As a consequence, transcriptional activation of Hedgehog target genes is repressed via SIN3-HDAC or SKI-HDAC-dependent mechanisms. Activation of the pathway ( fig. 1 b, right ) results in derepression of SMO, initiating a cascade disassembling the GLI-COSTAL-FUSED-SUFU complex, thereby allowing the activator forms of GLI to translocate to the nucleus and activate gene transcription. In cancer cells, recent reports suggest that GLI activity can be modulated in a Hedgehog-independent manner through the RAS-MEK/AKT pathway, which regulates the subcellular localization and protein stability of GLI transcription factors [16] [17] [18] ( fig. 1 c, left) . In addition, Dennler et al. [19] demonstrate that TGF-␤ can increase GLI expression and prolonged Hedgehog signaling through SMAD3-dependent mechanisms [18] ( fig. 1 c, right) . Thus, together these results expand our understanding of the complex network implicated in the regulation of GLI function in cancer cells and serve as a foundation for the development of new therapeutic approaches targeting the activity of these transcription factors.
